NOS2 and cancer: We selected four human cancer cell lines derived from aggressive tumor types that are known to express NOS2 and synthesize NO in vivo (MDA-MB-231 and MDA-MB-668 are TNBC, PC-3 is prostate, and U251 is glioblastoma).